why choose us

First received: August 08, 2022

Clinical Trial: An Intervention Study of Compound Silymarin in Patients With Non-alcoholic Fatty Liver Disease

Study Status: Completed

Recruit Status: RECRUITING

Condition: Nonalcoholic Fatty Liver Disease

Study Type: INTERVENTIONAL


Official Title: Effects of Compound Silymarin on Biomarkers of Lipid Metabolism and Inflammation in Patients With Non-alcoholic Fatty Liver Disease: A Randomized Controlled Double-blind Trial

Brief Summary: Non-alcoholic fatty liver disease (NAFLD) has become the most prevalent liver disorder in China.The aim of this project is to evaluate the effects of compound silymarin on biomarkers of lipid metabolism and inflammation in the patients with NAFLD.

Read more